Search NASA⌕ Search

SEARCH · Search NASA

Results for “Assay”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 37 records · Page 2

Investigation of magnetic nanoparticles for the rapid extraction and assay of alpha-emitting radionuclides from urine: Demonstration of a novel radiobioassay method

In the event of an accidental or intentional release of radionuclides into a populated area, three things must occur in a timely manner: food and drinking water supplies must be determined to be safe to eat / drink, civilians and/or military personnel must be surveyed to ensure that they do not have external contamination, and they must be screened to ensure that significant ingestion or inhalation of radionuclides has not occurred (this paper is concerned with the latter). In the event of such a disaster, the volume of radiobioassays to be performed would be tremendous. If the event released significant levels of β- or α-emitting radionuclides, in vivo assays would be ineffective. Therefore, highly efficient and rapid analytical methods for radionuclide detection from submitted spot urine samples (≤ 50 mL) would be required. At present, the quantitative determination of α-emitting radionuclides from urine samples is highly labor intensive, and requires significant sample preparation and analysis time. Sorbent materials that provide effective collection and enable rapid assay could significantly streamline the radioanalytical process. We have demonstrated the use of paramagnetic nanoparticles as a novel class of extracting media for four α-emitting radionuclides of concern (Po, Ra, Am, and U) from chemically unmodified and pH 2 human urine. Herein the initial experimental sorption results are presented along with a novel method that utilizes paramagnetic nanoparticles for the extraction of radionuclides from unmodified human urine followed by the magnetic field-induced collection of the particles for subsequent α-counting-source preparation. Additionally, we construct a versatile human dose model that determines the detector count times required to estimate internal human dose at specific protective action thresholds. The model provides a means to assess a method’s detection capabilities and use fundamental health physics parameters and actual experimental data as core variables. The modeling shows that with effective sorbent materials, rapid screening for internalized α-emitters is possible from a 50 mL spot urine sample volume collected within one week of exposure/intake.

59 BASIC BIOLOGICAL SCIENCES↗

Diagnostic Testing for COVID-19 Bridging Study for CDC EUA assays vs CDC Multiplex N1 FAM, N2 SUN, RNAse P ATTO 647 Assays

This report describes testing performed by LANL’s Biological Agent Testing Laboratory (BATL) to validate modifications to the CDC EUA 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel (EUA-CDC-nCoV-IFU). BATL intends to implement the modification to increase thoughput for daily testing. BATL validated the original component, CDC designed primers and probes purchased from IDT (Cat # 10006770) and the new component, CDC assays designed with new Reporter dyes allowing the assays to be multiplexed, IDT (Cat # 10006830, 10006831, 10006823, 10006833, 10006834, 10007050, 10006836, 10006837, 10007062)

59 BASIC BIOLOGICAL SCIENCES↗

A Novel and Secure Pseudovirus Reporter System Based Assay for Neutralizing and Enhancing Antibody Assay Against Marburg Virus

Marburg virus (MARV) is one of the principal members of the filovirus family, which can cause fatal hemorrhagic fever in humans. There are currently no prophylactic and therapeutic drugs on the market, and the high pathogenicity and infectivity of MARV make its research highly dependent on biosafety level 4 conditions, severely hindering the development of vaccines and therapies. Therefore, the development of medicines, such as MARV serological diagnosis, vaccines, and therapeutic antibody drugs, urgently needs a safe, convenient, and biosafety level 2 detection method to measure the neutralizing activity of MARV antibodies. To this end, we report a neutralization assay relying on a Rabies virus (RABV) reverse genetic operating system. We constructed infectious clones carrying the eGFP reporter gene and the full length of the original unmodified MARV GP gene. Based on the critical parameters of phylogenetic analysis, recombinant viruses targeting representative strains in the two major MARV lineages were successfully rescued. These pseudoviruses are safe in mice, and their inability to infect cells after being neutralized by antibodies can be visualized under a fluorescence microscope. We tested the system using the neutralizing antibody MR191. MR191 can significantly block the infection of BSR cells with pseudovirus. We compared it with the traditional lentivirus-type pseudovirus system to verify the system’s credibility and obtained the same results as reported in the literature. In general, we have established a safe and visualized method for evaluating the neutralizing activity of MARV antibodies. Compared with traditional methods, it has the advantages of convenient operation, short cycle, and low cost. It is a candidate method that can replace actual viruses for a neutralization assay.

Bi, Jinhao↗

NWAL Validation Report for U Assay by Potentiometric Titration (Modified Davies and Gray Technique) and U and PU Assay by Isotope Dilution Mass Spectrometry

SRNL Sensing & Metrology, previously Analytical Laboratory, is a member of the IAEA Network of Analytical Laboratories for Nuclear Material Measurement that is qualified to provide Uranium and Plutonium isotopic analysis of nuclear materials by Thermal Ionization Mass Spectrometry. As part of the membership, SRNL participated in the 2019 Nuclear Material Round Robin to maintain the qualification to provide isotopic analysis. SRNL also participated with the additional intent to qualify Uranium Assay by Potentiometric Titration (Davies and Gray method) and Uranium and Plutonium Isotope Dilution by Thermal Ionization Mass Spectrometry as part of the International Atomic Energy Agency’s Network of Analytical Laboratories. The proficiency test exercise was conducted by the Office of Safeguards Analytical Services, Department of Safeguards.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

The Phosphorylated ATM Immunofluorescence Assay: A High-performance Radiosensitivity Assay to Predict Postradiation Therapy Overreactions

The ability to identify, before treatment, those patients who will overreact to radiation therapy would have sound positive clinical implications. By focusing on DNA double-strand breaks recognition and repair proteins after irradiation, we recently demonstrated that the maximal number of phosphorylated ATM (pATM) nuclear foci in the first hour (pATMmax) after ex vivo irradiation correlated with postradiation therapy toxicity severity. We performed additional analyses of our whole collection of fibroblast lines to refine the predictive performance of our assay.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Exploring simultaneous single and coincident gamma-ray measurements for U/Pu assay in safeguards

Using a broad range of gamma-ray uranium standards and two plutonium samples of known isotopic content, list mode gamma ray information from two Compton suppressed and one planar HPGe detectors were analyzed according to the time information of the signals. Interferences from Cs-137 were introduced. In this study, we extended singles measurements by exploring the potential of simultaneously using both singles and coincidence data for U/Pu assay. The main goals of this exploratory study are: 1) whether one will be able to use coincidence information in addition to the complicated 100-keV unfolding to obtain extra information of uranium and plutonium isotopic ratios, and 2) with higher energy interference gamma-rays from isotopes such as Cs-137, can the coincidence information help to provide the isotopic information. (authors)

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗

Identification of proteins capable of metal reduction from the proteome of the Gram‐positive bacterium D esulfotomaculum reducens MI ‐1 using an NADH ‐based activity assay

Summary Understanding of microbial metal reduction is based almost solely on studies of G ram‐negative organisms. In this study, we focus on D esulfotomaculum reducens MI ‐1, a G ram‐positive metal reducer whose genome lacks genes with similarity to any characterized metal reductase. Using non‐denaturing separations and mass spectrometry identification, in combination with a colorimetric screen for chelated F e( III )‐ NTA reduction with NADH as electron donor, we have identified proteins from the D . reducens proteome not previously characterized as iron reductases. Their function was confirmed by heterologous expression in E scherichia coli . Furthermore, we show that these proteins have the capability to reduce soluble C r( VI ) and U ( VI ) with NADH as electron donor. The proteins identified are NADH : flavin oxidoreductase ( D red_2421) and a protein complex composed of oxidoreductase flavin adenine dinucleotide/ NAD ( P )‐binding subunit ( D red_1685) and dihydroorotate dehydrogenase 1B ( D red_1686). D red_2421 was identified in the soluble proteome and is predicted to be a cytoplasmic protein. D red_1685 and D red_1686 were identified in both the soluble as well as the insoluble protein fraction, suggesting a type of membrane association, although PSORTb predicts both proteins are cytoplasmic. This study is the first functional proteomic analysis of D . reducens and one of the first analyses of metal and radionuclide reduction in an environmentally relevant G ram‐positive bacterium.

Otwell, Anne Elyse↗

Isolation of Physiologically Active Thylakoids and Their Use in Energy-Dependent Protein Transport Assays

Chloroplasts are the organelles in green plants responsible for carrying out numerous essential metabolic pathways, most notably photosynthesis. Within the chloroplasts, the thylakoid membrane system houses all the photosynthetic pigments, reaction center complexes, and most of the electron carriers, and is responsible for light-dependent ATP synthesis. Over 90% of chloroplast proteins are encoded in the nucleus, translated in the cytosol, and subsequently imported into the chloroplast. Further protein transport into or across the thylakoid membrane utilizes one of four translocation pathways. Here, we describe a high-yield method for isolation of transport-competent thylakoids from peas (Pisum sativum), along with transport assays through the three energy-dependent cpTat, cpSec1, and cpSRP-mediated pathways. We report these methods enable experiments relating to thylakoid protein localization, transport energetics, and the mechanisms of protein translocation across biological membranes.

59 BASIC BIOLOGICAL SCIENCES↗

RuBisCO activity assays: a simplified biochemical redox approach for in vitro quantification and an RNA sensor approach for in vivo monitoring

Abstract Background Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) is the most abundant soluble protein in nature. Extensive studies have been conducted for improving its activity in photosynthesis through approaches like protein engineering. Concurrently, multiple biochemical and radiolabeling assays have been developed for determining its activity. Although these existing assays yield reliable results, they require addition of multiple external components, rendering them less convenient and expensive. Therefore, in this study, we have developed two relatively cheaper, convenient, and easily reproducible assays for quantitative and qualitative estimation of RuBisCO activity. Results We simplified a contemporary NADH based spectrophotometric RuBisCO assay by using cyanobacterial cell lysate as the source for Calvin cycle enzymes. We analyzed the influence of inorganic carbon substrates, CO 2 and NaHCO 3 , and varying protein concentrations on RuBisCO activity. Ribulose-1,5-bisphosphate (RuBP) consumption rates for the cultures grown under 5% CO 2 were 5–7 times higher than the ones grown with 20 mM NaHCO 3 , at different protein concentrations. The difference could be due to the impaired activity of carbonic anhydrase in the cell lysate, which is required for the conversion of HCO 3 − to CO 2 . The highest RuBisCO activity of 2.13 nmol of NAD + / µg of Chl-a/ min was observed with 50 µg of protein and 5% CO 2 . Additionally, we developed a novel RNA-sensor based fluorescence assay that is based on the principle of tracking the kinetics of ATP hydrolysis to ADP during the conversion of 3-phosphoglycerate (3-PG) to 1,3-bisphosphoglycerate (1,3-BPG) in the Calvin cycle. Under in vitro conditions, the fluorometric assay exhibited ~ 3.4-fold slower reaction rate (0.37 min −1 ) than the biochemical assay when using 5% CO 2 . We also confirmed the in vivo application of this assay, where increase in the fluorescence was observed with the recombinant strain of Synechocystis sp. PCC 6803 (SSL142) expressing the ADP-specific RNA sensor, compared to the WT. In addition, SSL142 exhibited three-fold higher fluorescence when supplemented with 20 mM NaHCO 3 as compared to the cells that were grown without NaHCO 3 supplementation. Conclusions Overall, we have developed a simplified biochemical assay for monitoring RuBisCO activity and demonstrated that it can provide reliable results as compared to the prior literature. Furthermore, the biochemical assay using 5% CO 2 (100% relative activity) provided faster RuBP consumption rate compared to the biochemical assay utilizing 20 mM NaHCO 3 (30.70% relative activity) and the in vitro fluorometric assay using 5% CO 2 (29.64% relative activity). Therefore, the absorbance-based biochemical assay using 5% CO 2 or higher would be suitable for in vitro quantification of the RuBisCO activity. On the other hand, the RNA-sensor based in vivo fluorometric assay can be applied for qualitative analysis and be used for high-throughput screening of RuBisCO variants. As RuBisCO is an enzyme shared amongst all the photoautotrophs, the assays developed in this study can easily be extended for analyzing the RuBisCO activities even in microalgae and higher plants.

59 BASIC BIOLOGICAL SCIENCES↗

The relevance of chemical interactions with CYP17 enzyme activity: Assessment using a novel in vitro assay

The steroidogenic cytochrome P450 17 (CYP17) enzyme produces dehydroepiandrosterone (DHEA), which is the most abundant circulating endogenous sex steroid precursor. DHEA plays a key role in e.g. sexual functioning and development. To date, no rapid screening assay for effects on CYP17 is available. In this study, a novel assay using porcine adrenal cortex microsomes (PACMs) was described. Effects of twenty-eight suggested endocrine disrupting compounds (EDCs) on CYP17 activity were compared with effects in the US EPA validated H295R (human adrenocorticocarcinoma cell line) steroidogenesis assay. In the PACM assay DHEA production was higher compared with the H295R assay (4.4 versus 2.2 nmol/h/mg protein). To determine the additional value of a CYP17 assay, all compounds were also tested for interaction with CYP19 (aromatase) using human placental microsomes (HPMs) and H295R cells. 62.5% of the compounds showed enzyme inhibition in at least one of the microsomal assays. Only the cAMP inducer forskolin induced CYP17 activity, while CYP19 was induced by four test compounds in the H295R assay. These effects remained unnoticed in the PACM and HPM assays. Diethylstilbestrol and tetrabromobisphenol A inhibited CYP17 but not CYP19 activity, indicating different mechanisms for the inhibition of these enzymes. From our results it becomes apparent that CYP17 can be a target for EDCs and that this interaction differs from interactions with CYP19. Our data strongly suggest that research attention should focus on validating a specific assay for CYP17 activity, such as the PACM assay, that can be included in the EDC screening battery. - Highlights: ► DHEA, produced by CYP17, plays a key role in sexual functioning and development. ► No rapid screening assay for effects on CYP17 is available yet. ► A novel assay using porcine adrenal cortex microsomes (PACMs) was described. ► Endocrine disrupting compounds (EDCs) targeting CYP17 interact differently with CYP19. ► A specific CYP17 assay is a valuable screening for effects early in steroidogenesis.

60 APPLIED LIFE SCIENCES↗

Low Background Materials and Assay: A Supplement to the Cosmic Frontier CF1 Summary.

Executive Summary The next generation of direct detection dark matter experiments will require stringent radiopurity in their target materials, internal instrumentation, and shielding components. A survey of major material assay facilities worldwide and of anticipated assay needs of generation 2 (G2) experiments indicate the current assay capability is marginally adequate in sensitivity and inadequate in throughput. High purity germanium (HPGe) gamma-ray assay has been the workhorse for material screening. It appears hundreds of samples will require screening at the limits of current achievable HPGe sensitivity. Mass spectroscopy methods and neutron activation analysis have demonstrated superior assay sensitivity in some specific cases. However, they are also currently throughput limited. In addition, both alpha/beta screening and radon emanation analysis at or beyond the current achievable sensitivity levels will be needed for dozens of samples. Experiments that follow G2 will have even more stringent material radiopurity specifications, exceeding current assay capabilities in both sensitivity and throughput. These screening needs must precede the commissioning of experiments by 3-5 years to inform design and quality control of components. Achieving the radiopurity goals of the next decade’s experiments will require investment in new techniques and tools to improve material assay sensitivity and throughput. Engineered low-background materials are a significant R&D expenditure, requiring developmental lead-time, and should benefit many end-user experiments. Reserving underground real estate for assay methods affected by cosmic rays (e.g. HPGe) and engineered radiopure materials activated by cosmic rays (e.g. electroformed copper) is judicious forward planning. In many cases, these spaces will require radon-suppressed sample preparation and material storage space. The above-mentioned survey of material assay facilities indicated very little development is taking place to improve sensitivity or throughput capability. In order to create the necessary infrastructure, it may help to form a consortium of low-background assay centers in the U.S that is managed by a scientific board with representatives from the community. This would provide for common use of existing screening facilities and a unified plan for new infrastructure and site development (see the Facilities White Paper). Such a loose organization already exists as AARM (Assay and Acquisition of Radiopure Materials), which is currently populating a community-wide materials database with published assay information. A more formal organization such as a Consortium is being actively investigated with DOE and NSF. Eventually, results of all screening performed in Consortium assay centers could be input directly to the open-access database, reducing duplication and providing for more efficient vendor selection.

Cooley-Sekula, Jodi↗

A Multiplexed Fluorescent Calcium and NFAT Reporter Gene Assay to Identify GPCR Agonists

Intracellular calcium response and resulting calcium signaling to an agonist-GPCR interaction are important for the measurement of compound activity in the GPCR drug development. The increase in cytosol calcium concentration can be measured by the fluorescent calcium indicator dye such as Fluo-4 in a quick assay (in 3-5 minutes) using the fluorescence imaging plate reader. The calcium signaling through the transcription factors such as NFAT that induces gene expression can be measured by the reporter gene assay that links to the expression of reporter enzyme such as the betalactamase that requires 5-hour incubation. We have evaluated a multiplexed assay that sequentially measures the calcium response to a GPCR agonist in a rapid fluorescent calcium dye assay, followed by a NFAT beta-lactamase assay, and compared them in the single assay format. We found that the agonist activity determined in the multiplexed assay were comparable with these determined in the single assay format and the Z’ factors were all >0.5. Five active compounds were identified that were active in both calcium dye assay and beta-lactamase assay. Therefore, our results demonstrated the utility of this multiplexed calcium assay for screening of GPCR compounds that can cross validate the primary hits and help to eliminate the false positive compounds.

59 BASIC BIOLOGICAL SCIENCES↗